Who owns VIVOS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vivos Therapeutics stock

Who bought or sold VIVOS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Strategic Wealth Designers 129k $1.6M 100% Dec 2023
 View chart
Armistice Capital 104k $500k 100% Mar 2024
 View chart
Commonwealth Equity Services 15k $72k 100% Mar 2024
 View chart
Vanguard Group 11k $51k 0% Mar 2024
 View chart
Credit Agricole 2.4k $62.909000 100% Mar 2024
 View chart
Newbridge Financial Services Group 2.0k $9.4k 51% Mar 2024
 View chart
Tower Research Capital 1.7k $8.4k 100% Mar 2024
 View chart
Signature 547.00 $2.6k 0% Mar 2024
 View chart
Group One Trading 228.00 $1.1k 100% Mar 2024
 View chart
Ronald Blue Trust 160.00 $772.992000 100% Mar 2024
 View chart
Bank of America Corporation 80.00 $386.000000 100% Mar 2024
 View chart
Morgan Stanley 67.00 $323.998600 100% Mar 2024
 View chart
Kozak & Associates 49.00 $110.999700 0% Mar 2024
 View chart
Global Retirement Partners 23.00 $111.000300 0% Mar 2024
 View chart
Steward Partners Investment Advisory 8.00 $39.000000 0% Mar 2024
 View chart
Royal Bank of Canada 7.00 $0 0% Mar 2024
 View chart
Wells Fargo & Company 7.00 $33.999700 0% Mar 2024
 View chart

Who sold out of Vivos Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Schonfeld Strategic Advisors Dec 2023 50k $623k
Cutler Dec 2023 12.00 $0